Business Development (Analytical Chemistry / Biology / Instrumentation)
Imspex Diagnostics is expanding its commercial team and we’re looking for a standout Business Development professional with a proven track record in analytical instrumentation. You’ll already be confident selling platforms such as HPLC, LC-MS, GC, GC-MS, SPE, Flash, ICP, and Purification systems, and you know how to engage technically minded customers across clinical and industry […]
Imspex joins the Welsh Delegation at MEDICA 2025
Imspex Diagnostics joins Welsh Delegation at MEDICA, Düsseldorf Next week, Amber Jacobs, PR, Marketing & ESG Compliance Leader at Imspex Diagnostics, will be joining the Welsh Government’s life sciences delegation at MEDICA 2025 in Düsseldorf. MEDICA is one of the world’s largest trade fairs for medical technology, diagnostics, and healthcare innovation. Amber will represent Imspex […]
Imspex Diagnostics at LSX Investival 2025
Imspex Diagnostics at LSX Investival Showcase, London Imspex Diagnostics CEO John McKinley and CFO Toby Wilson Waterworth will be attending the LSX Investival Showcase in London next week. The event brings together leaders from across the life sciences and investment communities to share innovation, insights, and opportunities for collaboration. John and Toby will be meeting […]
Imspex at the IABR Summit 2025
Representing Imspex Diagnostics at the forefront of global breath research Our Senior Research Scientist & Technical Support, Hannah Deane-Cutler, recently attended the International Association of Breath Research (IABR) Summit 2025 in Innsbruck, Austria. The event gathered researchers, clinicians, and industry leaders to share the latest developments in breath analysis across oncology, infectious diseases, gastrointestinal disorders, […]
Imspex to Present at BioSeed 2025
We’re pleased to share that Imspex Diagnostics will be represented at BioSeed 2025, taking place on 9 June in London. Hosted by OBN, BioSeed is a high-impact investment event that brings together early-stage R&D companies and a room full of active life sciences investors. John McKinley, our CEO & Director, will be presenting at the […]
Imspex at Arab Health 2025
Imspex Diagnostics is proud to announce our participation at Arab Health 2025, one of the world’s largest healthcare exhibitions, taking place from 27th to 30th January 2025 in Dubai. You can find us on the Welsh Government stand in Hall 2, Stand G30, where John McKinley (CEO) and Amber Jacobs (PR & Marketing Manager) will […]
Imspex Diagnostics Awarded SMART FIS Grant
Abercynon, Wales – November 28th, 2024. Imspex Diagnostics is pleased to announce its successful application for a SMART Flexible Innovation Support (SMART FIS) grant, awarded by the Welsh Government in support of the Company’s innovative research and development initiatives. This recognition underscores Imspex’s commitment to advancing use of cutting-edge analytical instruments and devices that deliver […]
Imspex & Biophys Partner to Drive SMART Diagnostics at New South Wales Lab
We are pleased to announce a significant collaboration between Imspex Diagnostics Ltd and Biophys Limited, aimed at advancing SMART diagnostics and R&D services. This partnership coincides with the recent opening of Biophys’s Class 2 laboratory at Mamhilad Park Estate in South Wales, which now provides quality-driven microbiological and R&D laboratory services across various industries. By […]
David Wilson Joins Imspex as Non-Executive Director
Imspex Diagnostics is pleased to announce the appointment of David Wilson to our board of directors as a Non-Executive Director. David brings over 30 years of international experience in the in-vitro diagnostic medical devices industry, providing deep expertise in mergers and acquisitions, business development, and global sales. His vast experience includes leadership roles at Genzyme […]
IMSPEX NEWS
PRESS RELEASE Imspex Announces Sale of Its German Subsidiary, Paving the Way for Standalone UK Entity Dedicated to Advancing Clinical Diagnostics and Leading in Breathomics. 15th May 2024, Abercynon, Wales – Imspex announces the sale of its German subsidiary, GAS Dortmund GmbH, to its majority shareholder, Hanon Group (China). This positions Imspex as a standalone […]
Meet Robin Curnow
📢IMSPEX Announcement: This week, Imspex presents our doctoral student, Robin Curnow, co-sponsored by us and the University of Manchester. Robin shares insights into his impactful work in Breathomics: “My PhD is in Breathomics which I am carrying out within the division of Immunology, Immunity to Infection and Respiratory Medicine at the University of Manchester. Breathomics […]
Meet Trenton Stewart
IMSPEX is proud to announce some of the current and upcoming projects led by one of our doctoral students, Trenton Stewart, co-sponsored by us and the University of Warwick. He is based in the Biomedical Sensors Laboratory in the School of Engineering while additionally being a Warwick Medical School student. His interdisciplinary research focuses on […]